Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Uterine Cancer Rates Skyrocketing in U.S., Study Finds The increasing uterine cancer rates appear to disproportionately affect women of color, who may not be getting the same quality of healthcare as other women in the U.S. May 12, 2022 Martha Garcia Add Your Comments Deaths from uterine cancer have increased in recent years in the U.S., largely due to an increase in a rare aggressive form of the cancer, according to the findings of a new study. Researchers in the U.S. and Denmark warn that mortality rates among women due to uterine cancer has increased over the last several years, but those increases have been largely dependent on race and ethnicity, and can be pinned on a rare, aggressive form of uterine cancer which has become more prevalent. Their findings were published on May 5 in JAMA Oncology. More than 65,000 cases of uterine cancer are diagnosed in the United States every year. Nearly 13,000 women will die as a result. Most types of cancers have seen improvements in treatment and early diagnosis, but the same is not the case for uterine cancer. Researchers studied more than 208,000 women with uterine cancer using data from the US Surveillance, Epidemiology, and End Results-18 Incidence-Based Mortality database, which represents 26% of the US population. The data included deaths from 2010 to 2017. Their findings identified a rare and aggressive form of uterine cancer known as Type 2 endometrial cancer, which was responsible for 20% of cases and 45% of uterine cancer deaths during that time. Deaths from Type 2 increased nearly 3% every year during the eight-year study period from 2010 to 2017. Deaths from less aggressive uterine cancer held the same during that time. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Overall, uterine cancer deaths increased by nearly 2% during the study period, mainly due to Type 2 endometrial cancer cases. The increases in deaths were much higher for women of certain racial and ethnic backgrounds, including Latina and Black women. Rates of uterine cancer increased by nearly 7% every year for Latina women, 3.5% for Black women, 3% for Asian women, and 1.5% for white women. Data from this study indicated Black women had twice the rate of deaths from all types of uterine cancer and for the more aggressive type, compared to women from other racial backgrounds. “Despite stable incidence rates, endometrioid cancer mortality rates have not decreased over the past decade at the population level, suggesting limited progress in treatment for these cancers,” the researchers concluded. “The substantial disparities in uterine corpus cancer mortality rates among non-Hispanic Black women cannot be fully explained by subtype distribution and stage at diagnosis.” Tags: Cancer, Endometriosis, Uterine Cancer Image Credit: | More Lawsuit Stories Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025 At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics March 14, 2025 Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 2 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 3 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 4 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025
Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 2 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 3 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 4 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)